Molecular imaging in the clinical arena

被引:276
作者
Jaffer, FA
Weissleder, R
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Cardiol Div, Boston, MA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 293卷 / 07期
关键词
D O I
10.1001/jama.293.7.855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Molecular imaging is an emerging field that aims to integrate patient-specific and disease-specific molecular information with traditional anatomical imaging readouts. The information provided by this field may ultimately allow for noninvasive or minimally invasive molecular diagnostic capabilities, better clinical risk stratification, more optimal selection of disease therapy, and improved assessment of treatment efficacy. In this update, we first provide an overview of clinically relevant molecular imaging technologies and imaging agents. Next, their applications to disease detection, drug discovery, and biomedical research are discussed. To specifically demonstrate the potential of molecular imaging, we highlight recent advances in clinical and preclinical molecular imaging of cancer and atherosclerosis.
引用
收藏
页码:855 / 862
页数:8
相关论文
共 55 条
[1]   Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for Pre-phase I positron emission tomography studies in cancer patients [J].
Aboagye, EO ;
Luthra, SK ;
Brady, F ;
Poole, K ;
Anderson, H ;
Jones, T ;
Boobis, A ;
Burtles, SS .
BRITISH JOURNAL OF CANCER, 2002, 86 (07) :1052-1056
[2]   Molecular-genetic imaging: current and future perspectives [J].
Blasberg, RG ;
Tjuvajev, AG .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (11) :1620-1629
[3]   Diffuse optical imaging of brain activation: approaches to optimizing image sensitivity, resolution, and accuracy [J].
Boas, DA ;
Dale, AM ;
Franceschini, MA .
NEUROIMAGE, 2004, 23 :S275-S288
[4]   In vivo molecular target assessment of matrix metalloproteinase inhibition [J].
Bremer, C ;
Tung, CH ;
Weissleder, R .
NATURE MEDICINE, 2001, 7 (06) :743-748
[5]   Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development [J].
Burns, HD ;
Hamill, TG ;
Eng, W ;
Francis, B ;
Fioravanti, C ;
Gibson, RE .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (04) :388-394
[6]   In vivo imaging of proteolytic activity in atherosclerosis [J].
Chen, JQ ;
Tung, CH ;
Mahmood, U ;
Ntziachristos, V ;
Gyurko, R ;
Fishman, MC ;
Huang, PL ;
Weissleder, R .
CIRCULATION, 2002, 105 (23) :2766-2771
[7]   Molecular, cellular and functional imaging of atherothrombosis [J].
Choudhury, RP ;
Fuster, V ;
Fayad, ZA .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (11) :913-925
[8]   PHASE-I AND IMAGING TRIAL OF INDIUM-111-LABELED ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODY 225 IN PATIENTS WITH SQUAMOUS-CELL LUNG-CARCINOMA [J].
DIVGI, CR ;
WELT, S ;
KRIS, M ;
REAL, FX ;
YEH, SDJ ;
GRALLA, R ;
MERCHANT, B ;
SCHWEIGHART, S ;
UNGER, M ;
LARSON, SM ;
MENDELSOHN, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (02) :97-104
[9]   Mammographic screening for breast cancer [J].
Fletcher, SW ;
Elmore, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1672-1680
[10]   Catheter-based in vivo imaging of enzyme activity and gene expression: Feasibility study in mice [J].
Funovics, MA ;
Weissleder, R ;
Mahmood, U .
RADIOLOGY, 2004, 231 (03) :659-666